Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.
Lewis A, Torvinen S, Dekhuijzen PNR, Chrystyn H, Melani A, Zöllner Y, Kolbe K, Watson AT, Blackney M, Plich A. Lewis A, et al. Among authors: blackney m. Respir Med. 2017 Aug;129:179-188. doi: 10.1016/j.rmed.2017.06.018. Epub 2017 Jun 27. Respir Med. 2017. PMID: 28732829 Free article.
The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom: Impact on Health Care Costs and Inhalation Technique.
Lewis A, Blackney M, Torvinen S, Holmes J, Osborne M, Dale J, Chandler S, Plich A. Lewis A, et al. Among authors: blackney m. Value Health. 2014 Nov;17(7):A591. doi: 10.1016/j.jval.2014.08.2027. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202019 Free article. No abstract available.
The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in Sweden.
Lewis A, Blackney M, Torvinen S, Lindqvist F, Safioti G, Grundström J, Polyzoi M, Plich A. Lewis A, et al. Among authors: blackney m. Value Health. 2014 Nov;17(7):A598-9. doi: 10.1016/j.jval.2014.08.2070. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202062 Free article. No abstract available.
23 results